Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection

Trends in Immunology

Volumn 24, Issue 4, 2003, Pages 165-168

  Suhrbier, Andreas ^a   La Linn, May ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT ENHANCEMENT; AUTOCRINE EFFECT; CYTOKINE PRODUCTION; DISEASE EXACERBATION; GENE EXPRESSION; HOST CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LIGATION; MACROPHAGE; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; TH2 CELL; VIRUS INFECTION;

EID: 0037383639     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00065-6     Document Type: Review

References (20)

1. Sullivan N.J. Antibody-mediated enhancement of viral disease. Burton D.R. Current Topics in Microbology and Immunology, 260 Antibodies in Viral Infection. 2001;145-169 Springer-Verlag.
2. Mahalingam S., Lidbury B.A. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κB) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. U. S. A. 99:2002;13819-13824.
3. Mahalingam S., et al. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J. Leukoc. Biol. 72:2002;429-439.
4. Takai T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2:2002;580-592.
5. Gerber J.S., Mosser D.M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166:2001;6861-6868.
6. Berlato C., et al. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168:2002;6404-6411.
7. Ito S., et al. Interleukin-10 inhibits expression of both interferon-α- and interferon-γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 93:1999;1456-1463.
8. Song M.M., Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:1998;35056-35062.
9. Redpath S., et al. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 9:2001;86-92.
10. Barrionuevo P., et al. Immune complexes (IC) down-regulate the basal and interferon-γ-induced expression of MHC class II on human monocytes. Clin. Exp. Immunol. 125:2001;251-257.
11. Novak N., et al. Engagement of FcεRI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J. Immunol. 16:2001;797-804.
12. Nigou J., et al. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:2001;7477-7485.
13. Doyle S.E., et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263.
14. Vadiveloo P.K., et al. Role of type I interferons during macrophage activation by lipopolysaccharide. Cytokine. 12:2000;1639-1646.
15. Haralambieva I.H., et al. Monoclonal antibody of IgG isotype against a cross-reactive lipopolysaccharide epitope of Chlamydia and Salmonella Re chemotype enhances infectivity in L929 fibroblast cells. FEMS Immunol. Med. Microbiol. 33:2002;71-76.
16. Baize S., et al. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128:2002;163-168.
17. Green S., et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59:1999;329-334.
18. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:2002;240-246.
19. Yang K.D., et al. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFN-γ production. J. Med. Virol. 63:2001;150-157.
20. Anderson C.F., Mosser D.M. Cutting edge: biasing immune responses by directing antigen to macrophage Fcγ receptors. J. Immunol. 168:2002;3697-3701.